US Pharm
. 2012;37(10):6. 

Nutley, NJ—Pharmaceutical company Roche is planning to open its new Translational Clinical Research Center in New York City at the end of 2013, transferring about 200 jobs from its site in Nutley, New Jersey. Earlier this year, the company announced it would close its 80-year-old New Jersey location, eliminating about 1,000 positions, although 50 management-level jobs will stay in the state. The new facility will handle the clinical development of experimental drug molecules discovered in Europe and manage interactions with the FDA. Roche’s primary research and development division, Genentech, will remain in the San Francisco area.

To comment on this article, contact